Cinnamon as a Cancer Therapeutic Agent

  • Neeru Bhatt
Chapter

Abstract

Multidisciplinary scientific investigations are continuously making efforts to combat this dreaded disease, but the perfect cure is yet to be brought into world medicine. Many types of cancer treatments are available depending on the type and stage of cancer and preference of the patient. The main types of cancer treatment include surgery, radiation therapy, chemotherapy, immunotherapy, target therapy, hormone therapy, adjuvant therapy, growth signal inhibitors, endogenous angioinhibitors, stem cell therapy, and precision medicine [1]. Each therapy has its own advantages and disadvantages. Some people prefer only one treatment, but most people have a combination of treatments, such as surgery along with chemotherapy and/or radiation therapy. If the disease has become metastasized and the targeted cancer cells are floating around in the bloodstream, multiple strategies should be adopted to get rid of the cancer.

References

  1. 1.
    Sudhakar A. History of cancer, ancient and modern treatment methods. J Cancer Sci Ther. 2009;1:i–iv.CrossRefGoogle Scholar
  2. 2.
    Esmonde L, Long AF. Complementary therapy use by persons with multiple sclerosis: benefits and research priorities. Complement Ther Clin Pract. 2008;14(3):176–84.CrossRefPubMedGoogle Scholar
  3. 3.
    Längler A, Kaatsch P, Spix C, et al. Complementary and alternative treatment methods in children with cancer. A population based retrospective survey on the prevalence of use in Germany. Eur J Integr Med. 2008;1(Suppl. 1):10–4.CrossRefGoogle Scholar
  4. 4.
    Miller JL, Binns HJ, Brickman WJ. Complementary and alternative medicine use in children with type 1 diabetes: a pilot survey of parents. EXPLORE J Sci Healing. 2008;4(5):311–4.Google Scholar
  5. 5.
    Kwon HK, Hwang JS, So JS, et al. Cinnamon extract induces tumor cell death through inhibition of NFkappaB and AP1. BMC Cancer. 2010;10:392.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Cravotto G, Boffa L, Genzini L, et al. Phytotherapeutics: an evaluation of the potential of 1000 plants. J Clin Pharm Ther. 2010;35:11–48.CrossRefPubMedGoogle Scholar
  7. 7.
    Patel B, Das S, Prakash R, et al. Natural bioactive compound with anticancer potential. Int J Adv Pharm Sci. 2010;1:32–41.CrossRefGoogle Scholar
  8. 8.
    Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer. 1992;18:1–29.CrossRefPubMedGoogle Scholar
  9. 9.
    Willett WC. Balancing life-style and genomics research for disease prevention. Science. 2002;296:695–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Middleton E Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev. 2000;52:673–751.PubMedGoogle Scholar
  11. 11.
    Watson WH, Cai J, Jones DP. Diet and apoptosis. Annu Rev Nutr. 2000;20:485–505.CrossRefPubMedGoogle Scholar
  12. 12.
    Yang CS, Landau JM, Huang MT, et al. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr. 2001;21:381–406.CrossRefPubMedGoogle Scholar
  13. 13.
    Priyadarsini RV, Nagini S. Cancer chemoprevention by dietary phytochemicals: promises and pitfalls. Curr Pharm Biotechnol. 2012;13:125–36.CrossRefPubMedGoogle Scholar
  14. 14.
    Shukla S, Meeran SM, Katiyar SK. Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention. Cancer Lett. 2014;355:9–17.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Umadevi M, Kumar KPS, Bhowmik D. Traditionally used anticancer herbs in India. J Med Plants Stud. 2013;1(3):56–72.Google Scholar
  16. 16.
    Kwon H, Jeon WK, Hwang J, et al. Cinnamon extract suppresses tumor progression by modulating angiogenesis and the effecter function of CD8þ T cells. Cancer Lett. 2009;278:174–82.CrossRefPubMedGoogle Scholar
  17. 17.
    Prakash O, Khan F. Cluster based SVR-QSAR modelling for HTS records: an implementation for anticancer leads against human breast cancer. Comb Chem High Throughput Screen. 2013;16:511–21.CrossRefPubMedGoogle Scholar
  18. 18.
    Balachandran P, Govindarajan R. Cancer: an ayurvedic perspective. Pharmacol Res. 2005;51:19–30.CrossRefPubMedGoogle Scholar
  19. 19.
    Singh IS, Ali W, Pathak RK. Effect of amalaki on experimental rats, with special reference to their nitrogen balance. J Res Indian Med. 1975;10:141–6.Google Scholar
  20. 20.
    Aggarwal BB, Ichikawa H, Garodia P, et al. From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opin Ther Targets. 2006;10:87–118.CrossRefPubMedGoogle Scholar
  21. 21.
    Chawla YK, Dubey P, Singh R, et al. Treatment of dyspepsia with Amalaki (Emblica officinalis Linn.)—an Ayurvedic drug. Indian J Med Res. 1982;76:95–8.PubMedGoogle Scholar
  22. 22.
    Mulabagal V, Subbaraju GV, Rao CV, et al. Withanolide sulfoxide from Aswagandha roots inhibits nuclear transcription factor-kappa-B, cyclooxygenase and tumor cell proliferation. Phytother Res. 2009;23:987–92.CrossRefPubMedGoogle Scholar
  23. 23.
    Vyas P, Thakar AB, Baghel MS, et al. Efficacy of Rasayana Avaleha as adjuvant to radiotherapy and chemotherapy in reducing adverse effects. Ayu. 2010;31:417–23.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Baliga MS, Meera S, Vaishnav LK, et al. Rasayana drugs from the Ayurvedic system of medicine as possible radioprotective agents in cancer treatment. Integr Cancer Ther. 2013;12:455–63.CrossRefPubMedGoogle Scholar
  25. 25.
    Shan B, Cai YZ, Brooks DJ, et al. Antibacterial properties and major bioactive component of cinnamon stick (Cinnamomum burmannii): activity against food has borne pathogenic bacteria. J Agric Food Chem. 2007;55:5484–90.CrossRefPubMedGoogle Scholar
  26. 26.
    Vinitha M, Ballal M. In vitro anticandidal activity of Cinnamomum verum. J Med Sci. 2008;8:425–8.CrossRefGoogle Scholar
  27. 27.
    Rana VS, Devi CB, Verdeguer N, et al. Variation of terpenoids constituents in natural population of Cinnamomum tamla (L.) leaves. J Essent Oil Res. 2009;21:531–4.CrossRefGoogle Scholar
  28. 28.
    Wang R, Wang R, Yang B. Extraction of essential oils from five cinnamon leaves and identification of their volatile compound compositions. Innovative Food Sci Emerg Technol. 2009;10:289–92.CrossRefGoogle Scholar
  29. 29.
    Kochummen KM. Family Lauraceae. In: Tree Flora of Malaya, vol. 4. Longmans: Kuala Lumpur; 1989. p. 124–32.Google Scholar
  30. 30.
    Jayatilaka A, Poole SK, Poole CF, et al. Simultaneous microsteam distillation/ solvent extraction for the isolation of semivolatile flavor compounds from Cinnamomum, their separation by series of coupled-column gas chromatography. Anal Chim Acta. 1995;302:147–62.CrossRefGoogle Scholar
  31. 31.
    Ranasinghe P, Perera S, Gunatilake M, et al. Effects of Cinnamomum zeylanicum (Ceylon cinnamon) on blood glucose and lipids in a diabetic and healthy rat model. Pharm Res. 2012;4:73–9.Google Scholar
  32. 32.
    Al-Numair KS, Ahemed D, Ahemed SE et al. Nutritive value, levels of polyphenols and anti-nutritional factors in Sri Lankan cinnamon (Cinnamomum Zeyalnicum) and Chinese cinnamon (Cinnamomum Cassia). Res. Bult., No. (154), Food Sci. & Agric. Res. Center, King Saud Univ 5–21. 2007.Google Scholar
  33. 33.
    Gul S, Safdar M. Proximate composition and mineral analysis of cinnamon. Pak J Nutr. 2009;8(9):1456–60.CrossRefGoogle Scholar
  34. 34.
    Senanayake UM, Lee TH, Wills RBH. Volatile constituents of cinnamon (Cinnamomum zeylanicum) oils. J Agric Food Chem. 1978;26(4):822–4.CrossRefGoogle Scholar
  35. 35.
    Singh G, Maurya S, DeLampasona MP, et al. A comparison of chemical, antioxidant and antimicrobial studies of cinnamon leaf and bark volatile oils, oleoresins and their constituents. Food Chem Toxicol. 2007;45:1650–61.CrossRefPubMedGoogle Scholar
  36. 36.
    Tung YT, Chua MT, Wang SY, et al. Antiinflammation activities of essential oil and its constituents from indigenous cinnamon (Cinnamomum osmophloeum) twigs. Bioresour Technol. 2008;99(9):3908–13.CrossRefPubMedGoogle Scholar
  37. 37.
    Tung YT, Yen PL, Lin CY, et al. Antiinflammatory activities of essential oils and their constituents from different provenances of indigenous cinnamon (Cinnamom umosmophloeum) leaves. Pharm Biol. 2010;48(10):1130–6.CrossRefPubMedGoogle Scholar
  38. 38.
    PROGRAM, NT. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Trans-Cinnamaldehyde. Technical Report 514 NIH Publication No 04-4448. 2004.Google Scholar
  39. 39.
    Elshafie MM, Nawar IA, Algamal MA, et al. Evaluation of the biological effects for adding cinnamon volatile oil and TBHQ as antioxidant on rats’lipid profiles. Asian J Plant Sci. 2012;11:100–8.CrossRefGoogle Scholar
  40. 40.
    Duke JA, Duke PAK, duCellier JL. Duke’s handbook of medicinal plants of the bible. Boca Raton: CRC Press; 2008.Google Scholar
  41. 41.
    Lu J, Zhang K, Nam S, et al. Novel angiogenesis inhibitory activity in cinnamon extract blocks VEGFR2 kinase and downstream signaling. Carcinogenesis. 2010;31:481–8.CrossRefPubMedGoogle Scholar
  42. 42.
    Molania T, Moghadamnia A, Aghel S, et al. The effect of cinnamaldehyde on mucositis and salivary antioxidant capacity in gamma-irradiated rats (a preliminary study). J Pharm Sci. 2012;20:89–95.Google Scholar
  43. 43.
    Hong JW, Yang GE, Kim YB, et al. Anti-inflammatory activity of cinnamon water extract in vivo and in vitro LPS-induced models. BMC Complement Altern Med. 2012;12:237–41.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Elahi RK. The effect of the cinnamon on dog’s heart performance by focus on Korotkoff sounds. J Anim Vet Adv. 2012;11:3604–8.CrossRefGoogle Scholar
  45. 45.
    Akira M, Tanaka S, Tabata M. Pharmacological studies on the antiulcerogenic activity of Chinese cinnamon. Planta Med. 1986;6:440–3.CrossRefGoogle Scholar
  46. 46.
    Sharma UK, Sharma AK, Pandey AK. Medicinal attributes of major phenylpropanoids present in cinnamon. BMC Complement Altern Med. 2016;16:156.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Koppikar SJ, Choudhari AS, Suryavanshi SA, et al. Aqueous cinnamon extract (ACE-c) from the bark of Cinnamomum Cassia causes apoptosis in human cervical cancer cell line (SiHa) through loss of mitochondrial membrane potential. BMC Cancer. 2010;10:210.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Jeon CY, Haan MN, Cheng C, et al. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care. 2012;35:520–5.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Choi J, Lee KT, Ka H, et al. Constituents of the essential oil of the cinnamon cassia stem bark and the biological properties. Arch Pharm Res. 2001;24(5):418–23.CrossRefPubMedGoogle Scholar
  50. 50.
    Swords R, Kelly K, Carew J, et al. The Pim kinases: new targets for drug development. Curr Drug Targets. 2011;12(14):2059–66.CrossRefPubMedGoogle Scholar
  51. 51.
    Blanco-Aparicio C, Carnero A. Pim kinases in cancer: diagnostic, prognostic and treatment opportunities. Biochem Pharmacol. 2013;85(5):629–43.CrossRefPubMedGoogle Scholar
  52. 52.
    Kim JE, Son JE, Jeongc H, et al. A novel cinnamon-related natural product with Pim-1 inhibitory activity inhibits leukemia and skin cancer. Cancer Res. 2015;75(13):2716–28.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Ono K, Wang X, Han J. Resistance to tumor necrosis factor-induced cell death mediated by PMCA4 deficiency. Mol Cell Biol. 2001;21:8276–88.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Tsai KD, Liu YH, Chen TW, et al. Cuminaldehyde from Cinnamomum verum induces cell death through targeting topoisomerase 1 and 2 in human colorectal adenocarcinoma COLO 205 cells. Forum Nutr. 2016;8:318–25.Google Scholar
  55. 55.
    Yang S, Tsai K, Wong HY, et al. Molecular mechanism of Cinnamomum verum component cuminaldehyde inhibits cell growth and induces cell death in human lung squamous cell carcinoma NCI-H520 cells in vitro and in vivo. J Cancer. 2016;7:251–61.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Evdokimova OV, Neneleva EV, Tarrab I, et al. Comparison of lipophilic substances of the bark of Chinese (Cinnamomum cassia (L.) C. Presl.) and Ceylon cinnamon (Cinnamomum zeylanicum Blume). World Appl Sci J. 2013;27:70–3.Google Scholar
  57. 57.
    Bhattacharjee S, Rana T, Sengupta A. Inhibition of lipid peroxidation and enhancement of GST activity by cardamom and cinnamon during chemically induced colon carcinogenesis in Swiss albino mice. Asian Pac J Cancer Prev. 2007;8:578–82.PubMedGoogle Scholar
  58. 58.
    Schoene NW, Kelly MA, Polansky MM, et al. A polyphenol mixture from cinnamon targets p38MAP kinase-regulated signaling pathways to produce G2/M arrest. J Nutr Biochem. 2009;20:614–20.CrossRefPubMedGoogle Scholar
  59. 59.
    Assadollahi V, Parivar K, Roudbari NH, et al. The effect of aqueous cinnamon extract on the apoptotic process in acute myeloid leukemia HL-60 cells. Adv Biomed Res. 2013;2:25–9.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Aleo E, Henderson CJ, Fontanini A, et al. Identification of new compounds that trigger apoptosome-independent caspase activation and apoptosis. Cancer Res. 2006;66:9235–44.CrossRefPubMedGoogle Scholar
  61. 61.
    Niki E, Yoshida Y, Saito Y, et al. Lipid per-oxidation: mechanisms, inhibition, and biological effects. Biochem Biophys Res Commun. 2005;338:668–76.CrossRefPubMedGoogle Scholar
  62. 62.
    Ames BM, Shigena MK, Hagen TM. Oxidants, antioxidants and the degenerative diseases of aging. Proc. Natl. Acad Sci. 1993;90:7915–22.CrossRefGoogle Scholar
  63. 63.
    United Stated Department of Agriculture [USDA]. USDA Database for the Flavonoid Content of Selected Food s, Release 2.1. 2007. http://www.ars.usda.gov/SP2User Files/Place/12354500/Data/Flav/flav02-1.mdb. Accessed 21 June 21 2017.
  64. 64.
    Murcia MA, Egea I, Romojaro F, et al. Antioxidant evaluation in dessert spices compared with common food additives. Influence of irradiation procedure. J Agric Food Chem. 2004;52(2):1872–81.CrossRefPubMedGoogle Scholar
  65. 65.
    Shobana S, Naidu KA. Antioxidant activity of selected Indian spices. Prostaglandins Leukot Essent Fatty Acids. 2000;62(2):107–10.CrossRefPubMedGoogle Scholar
  66. 66.
    Okawa M, Kinjo J, Nohara T, et al. DPPH (1,1-diphenyl-2-Picrylhydrazyl) radical scavenging activity of flavonoids obtained fromsomemedicinal plants. Biol Pharm Bull. 2001;24(10):1202–5.CrossRefPubMedGoogle Scholar
  67. 67.
    Lin CC, Wu SJ, Chang CH, et al. Antioxidant activity of Cinnamomum cassia. Phytother Res. 2003;17(7):726–30.CrossRefPubMedGoogle Scholar
  68. 68.
    Grzanna R, Lindmark L, Frondoza CG. Gingeran herbal medicinal product with broad anti-inflammatory actions. J Med Food. 2005;8(2):125–32.CrossRefPubMedGoogle Scholar
  69. 69.
    Youn HS, Lee JK, Choi YJ, et al. Cinnamaldehyde suppresses toll-like receptor 4 activation mediated through the inhibition of receptor oligomerization. Biochem Pharmacol. 2008;75(2):494–502.CrossRefPubMedGoogle Scholar
  70. 70.
    Yu T, Lee S, Yang WS, et al. The ability of an ethanol extract of Cinnamomum cassia to inhibit Src and spleen tyrosine kinase activity contributes to its anti-inflammatory action. J Ethnopharmacol. 2012;139(2):566–73.CrossRefPubMedGoogle Scholar
  71. 71.
    Han X, Parker TL. Antiinflammatory activity of cinnamon (Cinnamomum zeylanicum) bark essential oil in a human skin disease model. Phytother Res. 2017;31:1034–8.CrossRefPubMedPubMedCentralGoogle Scholar
  72. 72.
    Bhatt N. Herbs and herbal supplements a novel nutritional approach in animal nutrition. Iran J Appl Anim Sci. 2015;5(3):497–516.Google Scholar
  73. 73.
    Varalakshmi B, Vijaya Anand A, Karpagam T, et al. In vitro antimicrobial and anticancer activity of Cinnamomum zeylanicum linn bark extracts. Int J Pharm Pharm Sci. 2014;6(1):12–8.Google Scholar
  74. 74.
    Khan A, Bryden NA, Polansky MM, et al. Insulin potentiating factor and chromium content of selected foods and spices. Biol Trace Elem Res. 1990;24(3):183–8.CrossRefPubMedGoogle Scholar
  75. 75.
    Anderson RA, Broadhurst CL, Polansky MM, et al. Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J Agric Food Chem. 2004;52:65–70.CrossRefPubMedGoogle Scholar
  76. 76.
    Wang JM, Xu B, Rao JY, et al. Diet habits, alcohol drinking, tobacco smoking, green tea drinking, and the risk of esophageal squamous cell carcinoma in the Chinese population. Eur J Gastroenterol Hepatol. 2007;19:171–6.CrossRefPubMedGoogle Scholar
  77. 77.
    Subash Babu P, Prabuseenivasan S, Ignacimuthu S. Cinnamaldehyde—a potential antidiabetic agent. Phytomedicine. 2007;14(1):15–22.CrossRefPubMedGoogle Scholar
  78. 78.
    Hafizur RM, Hameed A, Shukrana M, et al. Cinnamic acid exerts anti-diabetic activity by improving glucose tolerance in vivo and by stimulating insulin secretion in vitro. Phytomedicine. 2015;22(2):297–300.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Neeru Bhatt
    • 1
  1. 1.Global Science HeritageTorontoCanada

Personalised recommendations